1-3 of 3
Mathias Freund, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

General Condition and Early Complications Have in Addition to Disease- Specific Factors a Significant Impact on Outcome - Prognostic Factors Revisited in 1657 Adult ALL Patients (15–55 years).

Nicola Goekbuget, MD, Renate Arnold, MD, PhD, Anja Baumann, MD, Joachim Beck, MD, Helmut Diedrich, MD, Mathias Freund, MD, PhD, Andreas Hüttmann, MD, PhD, Michael Kneba, MD, PhD, Karl Anton Kreuzer, MD, Lothar Leimer, MD, Thomas Lipp, MD, Dorle Messerer, Ralph Naumann, MD, PhD, Albrecht Reichle, MD, PhD, Harald Rieder, MD, PhD, Kerstin Schäfer-Eckart, MD, Marc Schmalzing, MD, Mathias Schmid, MD, PhD, Norbert Schmitz, MD, PhD, Hubert Serve, MD, PhD, Matthias Stelljes, MD, Eckhard Thiel, MD, PhD, Dieter Hoelzer, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1927.
https://doi.org/10.1182/blood.V112.11.1927.1927
Published: 2008
Journal Articles

The Effects of Induction Chemotherapy and High-Dose Melphalan with Tandem Autologous Transplantation in Multiple Myeloma: The Prospective Randomized DSMM 2 Study.

Christian Straka, MD, PhD, Peter Liebisch, MD, Burkhard Hennemann, MD, Bernd Metzner, MD, Hans Salwender, MD, Lothar Kanz, MD, PhD, Sigrid Adler-Reichel, MD, Wolf-Dieter Ludwig, MD, PhD, Hannes Wandt, MD, PhD, Martin Bentz, MD, PhD, Tim Bruemmendorf, MD, PhD, Markus Hentrich, MD, Lorenz Truemper, MD, PhD, Mathias Freund, MD, PhD, Hans-Heinrich Wolf, MD, Sezer Orhan, MD, PhD, Ralf Bargou, MD, PhD, Gottfried Doelken, MD, PhD, Norbert Schmitz, MD, PhD, Helga Bernhard, MD, PhD, Martin Gramatzki, MD, PhD, Norbert Frickhofen, MD, PhD, Helmut Ostermann, MD, PhD, Ralf Schmidmaier, MD, Stefan Ibach, PhD, Axel Hinke, PhD, Hermann Einsele, MD, PhD, Bertold Emmerich, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 446.
https://doi.org/10.1182/blood.V110.11.446.446
Published: 2007
Journal Articles

Improved Outcome in High Risk and Very High Risk ALL by Risk Adapted SCT and in Standard Risk ALL by Intensive Chemotherapy in 713 Adult ALL Patients Treated According to the Prospective GMALL Study 07/2003.

Nicola Gökbuget, MD, Renate Arnold, MD, PhD, Angelika Böhme, MD, PhD, Rainer Fietkau, MD, PhD, Mathias Freund, MD, PhD, Arnold Ganser, MD, PhD, Michael Kneba, MD, PhD, Thomas Lipp, MD, Wolf-Dieter Ludwig, MD, PhD, Georg Maschmeyer, MD, PhD, Dorle Messerer, Harald Rieder, MD, PhD, Eckard Thiel, MD, PhD, Dieter Hoelzer, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 12.
https://doi.org/10.1182/blood.V110.11.12.12
Published: 2007